Threshold Pharmaceuticals has signed a global agreement with Siemens Healthcare to purchase its investigational radiolabeled hypoxia positron emission tomography (PET) tracer, [18F]HX4 [flortanidazole (18F)]. The US-based biotechnology ...
Affibody has entered into a collaboration agreement with GE Healthcare to develop a Her2-targeted PET imaging agent for detecting breast and gastric cancer. The clinical trials for the Her2-targeted PET imaging agent is scheduled to ...
Tags: company cooperation, clinical research, breast cancer, gastric cancer